Higher levels of mTOR and a chronic activation of mTORC1 in tissues from obese mice and humans appears to play a key role in the development of insulin resistance and type 2 diabetes, which is supported by the results of treatments with metformin, which is known to negatively regulate the action of mTOR [37]. The gene discussed is MTOR; the disease is Insulin resistance.